Evaluate the Post-marketing Efficacy and Safety of Eptq S and Eptq Lidocaine S

Inclusion Criteria: * Male and Female adults aged 19 years and older. * Meet one of the following among individuals who want temporary improvement of facial wrinkles and volume. 1. Wrinkle Severity Rating Scale score 3 or 4 for Nasolabial fold. 2. Mid-Face Volume Deficit Scale score 3 or greater. 3. Medicis Lip Fullness Scale score 1-2. In cases of 2-1) and 2-2), participants must meet both sides (right and left) to be eligible for enrollment. For 3), the Medicis Lip Fullness Scale scores 1-2 at the target sites for procedures (upper lip, lower lip, up \& down) eligible for enrollment * Voluntarily agree to participate in this observational study in written consent form. Exclusion Criteria: * Received anti-thrombotics (except low-dose aspirin \[100 mg, maximum 300 mg/day\]) within 2 weeks from screening. * Currently have or have a history of bleeding disorder. * applied graft/prosthesis or biomaterials, including hyaluronic acid, polycaprolactone, collagen filler, lifting (threads, laser, etc.), and Botulinum toxin, at the site for indication within 24 weeks from screening. * Skin disorder or wound infection on the face that affects this study * Have history of side effects of EMLA cream or equivalent lidocaine agent. * History of hypersensitivity to hyaluronic acid agent(s). * Other contraindications as per the \[Precautions for Use\] in the approved label for the study device. * Determined as not eligible for the study by the investigator.